Dimaani, Salde .
HRN: 22-09-79 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2022
CEFUROXIME 750MG (VIAL)
10/22/2022
10/29/2022
IVTT
1000mg
Q8
UTI
Waiting Final Action